Last reviewed · How we verify
NCT03920761: ETNA
Evaluation of Technologies for Neonates in Africa
trial testing EarlySense Insight system in Neonatal Physiology in 575 participants. Completed in 30 December 2020.
15 December 2020
Quick facts
| Lead sponsor | Save the Children |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 575 |
| Start date | 27 June 2019 |
| Primary completion | 15 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 2 locations across Kenya |
Drugs / interventions tested
- EarlySense Insight system
- Advanced Neonatal Epidermal System
Conditions studied
- Neonatal Physiology — all drugs for Neonatal Physiology →
Sponsor
Save the Children — full company profile →
Who can join
Adults 1 Day to 28 Days, any sex, with Neonatal Physiology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a diagnostic accuracy evaluation and clinical feasibility study of investigational devices (EarlySense and ANNE systems) in a neonatal high dependency unit (nHDU) in a private teaching hospital and a government maternity hospital in Nairobi, Kenya. Neonates who are admitted for routine observation and care will be enrolled.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluation of non-invasive continuous physiological monitoring devices for neonates in Nairobi, Kenya: a research protocol.
Ginsburg AS, Nkwopara E, Macharia W, Ochieng R, et al · · 2020 · cited 15× · PMID 32284391 · DOI 10.1136/bmjopen-2019-035184 -
Qualitative study exploring the feasibility, usability and acceptability of neonatal continuous monitoring technologies at a public tertiary hospital in Nairobi, Kenya.
Kinshella MW, Naanyu V, Chomba D, Waiyego M, et al · · 2022 · cited 7× · PMID 35017248 · DOI 10.1136/bmjopen-2021-053486 -
Clinical feasibility of an advanced neonatal epidermal multiparameter continuous monitoring technology in a large public maternity hospital in Nairobi, Kenya.
Ginsburg AS, Zandi Nia S, Chomba D, Parsimei M, et al · · 2022 · cited 6× · PMID 35810244 · DOI 10.1038/s41598-022-16051-3 -
Clinical feasibility of a contactless multiparameter continuous monitoring technology for neonates in a large public maternity hospital in Nairobi, Kenya.
Ginsburg AS, Zandi Nia S, Chomba D, Dunsmuir D, et al · · 2022 · cited 5× · PMID 35197529 · DOI 10.1038/s41598-022-07189-1 -
Evaluation of a contactless neonatal physiological monitor in Nairobi, Kenya.
Wang D, Macharia WM, Ochieng R, Chomba D, et al · · 2022 · cited 4× · PMID 34740876 · DOI 10.1136/archdischild-2021-322344
Verify or expand the search:
- PubMed search for NCT03920761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Save the Children trials
Trials by the same sponsor.
- NCT03187067 — Pediatric Pneumonia Lung Ultrasound · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03920761 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Save the Children
- Last refreshed: 17 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing